Publication Venue For
- 364 POSTER Obatoclax in SCLC: preclincal evaluation of a BH3 mimetic 2008
- 4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a 2007
- 6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study 2007
- P59 Building a quality assurance (QA) system that is fit for purpose in an academic laboratory 2007
- 143 POSTER Comparison of cell death ELISAs applied as potential surrogate biomarkers in the clinical evalution of AEG35156 (XIAP antisense) 2006
- 427 POSTER Preclinical development of xiapuradamib therapy for lung cancer 2006
- 453 Validation of pharmacodynamic assays to determine the clinical effect of an antisense to the XIAP inhibitor of apoptosis 2004
- 494 Preliminary results from a phase I clinical trial of the bioreductive drug, RH1 2004
- 891 Impact of urethrography in high-precision prostate cancer radiotherapy 2003